Heart muscle blood flow study for dilated cardiomyopathy
Part of Genetic & congenital, Heart & circulation clinical trials.
This study looks at how small blood vessels in the heart affect outcomes in people with dilated cardiomyopathy (an enlarged, weak heart). You may qualify if you have heart failure with a weak pump and no significant blockages in your main heart arteries.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your heart is enlarged (left ventricle > 55 mm for men, > 50 mm for women on ultrasound)
- You have heart failure symptoms and a blood test for BNP or NT-proBNP is high
- Your heart's pumping strength (ejection fraction) is less than 45%
- You have had a heart catheterization showing no major blockages (less than 50% narrowing in any main artery)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to find and treat rare types of heart muscle disease early. If you have heart failure but no known heart disease, researchers will use MRI and other tests to see if a rare cause is behind your symptoms and then offer targeted treatment.
This study looks at whether certain antibodies (proteins in your blood) can help predict how dilated cardiomyopathy will progress. By testing your blood, researchers hope to learn more about your condition and find better ways to manage it.
This trial tests a protein filtering treatment (immunoadsorption) for people with dilated cardiomyopathy who have a specific antibody linked to heart damage. It aims to see if removing these antibodies can improve heart function.
This research uses cardiac MRI scans and patient data to better predict outcomes in people with dilated cardiomyopathy—a condition where the heart's main pumping chamber becomes enlarged and weakened. Participating could help doctors improve how they care for similar patients in the future.
This study checks if tiny blood vessel problems in the heart affect how well the heart muscle recovers after being weak. It uses special imaging during a routine heart catheterization to look at these small vessels.
This trial uses a heart MRI to measure details in people with dilated cardiomyopathy and reduced pumping strength. It aims to use these MRI findings to better predict your future heart risk and guide care.
Hear when a new Dilated Cardiomyopathy (DCM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.